Palwa, Nadia M.
HRN: 14-37-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/27/2025
03/27/2025
IV
4.5gms
Now
T/C Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes